# Carvana Co.: financial statements, quarterly

CVNA · NYSE · CIK 1690820 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cvna.md) · [Financials](/companies/cvna/financials.md) · [Filings](/companies/cvna/filings.md) · [Insiders](/companies/cvna/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cvna/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,773](/filings/0001690820-24-000345.md) | [2,424 d](/filings/0001690820-26-000009.md) | [3,061](/filings/0001690820-25-000161.md) | [3,410](/filings/0001690820-25-000312.md) | [3,655](/filings/0001690820-25-000353.md) | [3,547 d](/filings/0001690820-26-000009.md) | [4,232](/filings/0001690820-26-000035.md) | [4,840](/filings/0001690820-26-000055.md) | [5,647](/filings/0001690820-25-000353.md) | [5,603 d](/filings/0001690820-26-000009.md) | [6,432](/filings/0001690820-26-000035.md) | [7,376](/filings/0001690820-26-000055.md) |
| Cost of revenue | $m | [2,291](/filings/0001690820-24-000345.md) | [2,022 d](/filings/0001690820-26-000009.md) | [2,470](/filings/0001690820-25-000161.md) | [2,695](/filings/0001690820-25-000312.md) | [2,848](/filings/0001690820-25-000353.md) | [2,784 d](/filings/0001690820-26-000009.md) | [3,303](/filings/0001690820-26-000035.md) | [3,776](/filings/0001690820-26-000055.md) | [4,499](/filings/0001690820-25-000353.md) | [4,552 d](/filings/0001690820-26-000009.md) | [5,161](/filings/0001690820-26-000035.md) | [5,992](/filings/0001690820-26-000055.md) |
| Gross profit | $m | [482](/filings/0001690820-24-000345.md) | [402 d](/filings/0001690820-26-000009.md) | [591](/filings/0001690820-25-000161.md) | [715](/filings/0001690820-25-000312.md) | [807](/filings/0001690820-25-000353.md) | [763 d](/filings/0001690820-26-000009.md) | [929](/filings/0001690820-26-000035.md) | [1,064](/filings/0001690820-26-000055.md) | [1,148](/filings/0001690820-25-000353.md) | [1,051 d](/filings/0001690820-26-000009.md) | [1,271](/filings/0001690820-26-000035.md) | [1,384](/filings/0001690820-26-000055.md) |
| Selling, general and administrative | $m | [433](/filings/0001690820-24-000345.md) | [439 d](/filings/0001690820-26-000009.md) | [456](/filings/0001690820-25-000161.md) | [455](/filings/0001690820-25-000312.md) | [469](/filings/0001690820-25-000353.md) | [494 d](/filings/0001690820-26-000009.md) | [535](/filings/0001690820-26-000035.md) | [551](/filings/0001690820-26-000055.md) | [595](/filings/0001690820-25-000353.md) | [627 d](/filings/0001690820-26-000009.md) | [690](/filings/0001690820-26-000035.md) | [704](/filings/0001690820-26-000055.md) |
| Operating income | $m | [48.0](/filings/0001690820-24-000345.md) | [(38.0) d](/filings/0001690820-26-000009.md) | [134](/filings/0001690820-25-000161.md) | [259](/filings/0001690820-25-000312.md) | [337](/filings/0001690820-25-000353.md) | [260 d](/filings/0001690820-26-000009.md) | [394](/filings/0001690820-26-000035.md) | [511](/filings/0001690820-26-000055.md) | [552](/filings/0001690820-25-000353.md) | [424 d](/filings/0001690820-26-000009.md) | [581](/filings/0001690820-26-000035.md) | [680](/filings/0001690820-26-000055.md) |
| Interest expense | $m | [153](/filings/0001690820-23-000323.md) | [165 d](/filings/0001690820-24-000093.md) | [173](/filings/0001690820-24-000165.md) | [173](/filings/0001690820-25-000312.md) | [157](/filings/0001690820-25-000353.md) | [148 d](/filings/0001690820-26-000009.md) | [139](/filings/0001690820-26-000035.md) | [143](/filings/0001690820-26-000055.md) | [125](/filings/0001690820-25-000353.md) | [98.0 d](/filings/0001690820-26-000009.md) | [99.0](/filings/0001690820-26-000035.md) | [101](/filings/0001690820-26-000055.md) |
| Income tax | $m | [29.0](/filings/0001690820-24-000345.md) | [(2.0) d](/filings/0001690820-26-000009.md) | [(1.0)](/filings/0001690820-25-000161.md) | [1.0](/filings/0001690820-25-000312.md) | [(1.0)](/filings/0001690820-25-000353.md) | [(3.0) d](/filings/0001690820-26-000009.md) | [2.0](/filings/0001690820-26-000035.md) | [0.0](/filings/0001690820-26-000055.md) | [(4.0)](/filings/0001690820-25-000353.md) | [(2,783) d](/filings/0001690820-26-000009.md) | [36.0](/filings/0001690820-26-000035.md) | [66.0](/filings/0001690820-26-000055.md) |
| Net income | $m | [782](/filings/0001690820-24-000345.md) | [(114) d](/filings/0001690820-26-000009.md) | [28.0](/filings/0001690820-25-000161.md) | [18.0](/filings/0001690820-25-000312.md) | [85.0](/filings/0001690820-25-000353.md) | [79.0 d](/filings/0001690820-26-000009.md) | [216](/filings/0001690820-26-000035.md) | [183](/filings/0001690820-26-000055.md) | [151](/filings/0001690820-25-000353.md) | [857 d](/filings/0001690820-26-000009.md) | [250](/filings/0001690820-26-000035.md) | [310](/filings/0001690820-26-000055.md) |
| Diluted EPS | $ per share | [7.05](/filings/0001690820-23-000323.md) | not reported | [0.24](/filings/0001690820-24-000165.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [7.05](/filings/0001690820-23-000323.md) | not reported | [0.24](/filings/0001690820-24-000165.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001690820-24-000345.md) | [0.5](/filings/0001690820-26-000009.md) | [0.3](/filings/0001690820-25-000161.md) | [0.5](/filings/0001690820-25-000312.md) | [0.9](/filings/0001690820-25-000353.md) | [1.7](/filings/0001690820-26-000009.md) | [1.9](/filings/0001690820-26-000035.md) | [1.9](/filings/0001690820-26-000055.md) | [2.1](/filings/0001690820-25-000353.md) | [2.3](/filings/0001690820-26-000055.md) | [2.4](/filings/0001690820-26-000035.md) | [2.6](/filings/0001690820-26-000055.md) |
| Current assets | $bn | [3.2](/filings/0001690820-23-000323.md) | [3.3](/filings/0001690820-25-000074.md) | [3.2](/filings/0001690820-24-000165.md) | [3.5](/filings/0001690820-24-000272.md) | [3.8](/filings/0001690820-24-000345.md) | [4.9](/filings/0001690820-26-000009.md) | [5.1](/filings/0001690820-25-000161.md) | [5.7](/filings/0001690820-25-000312.md) | [6.3](/filings/0001690820-25-000353.md) | [6.5](/filings/0001690820-26-000055.md) | [7.2](/filings/0001690820-26-000035.md) | [8.0](/filings/0001690820-26-000055.md) |
| Total assets | $bn | [7.0](/filings/0001690820-23-000323.md) | [7.1](/filings/0001690820-25-000074.md) | [7.0](/filings/0001690820-24-000165.md) | [7.2](/filings/0001690820-24-000272.md) | [7.4](/filings/0001690820-24-000345.md) | [8.5](/filings/0001690820-26-000009.md) | [8.9](/filings/0001690820-25-000161.md) | [9.4](/filings/0001690820-25-000312.md) | [9.9](/filings/0001690820-25-000353.md) | [13.2](/filings/0001690820-26-000055.md) | [13.8](/filings/0001690820-26-000035.md) | [14.6](/filings/0001690820-26-000055.md) |
| Current liabilities | $bn | [1.4](/filings/0001690820-23-000323.md) | [1.5](/filings/0001690820-25-000074.md) | [1.3](/filings/0001690820-24-000165.md) | [1.1](/filings/0001690820-24-000272.md) | [1.2](/filings/0001690820-24-000345.md) | [1.3](/filings/0001690820-26-000009.md) | [1.3](/filings/0001690820-25-000161.md) | [1.4](/filings/0001690820-25-000312.md) | [1.5](/filings/0001690820-25-000353.md) | [1.5](/filings/0001690820-26-000055.md) | [1.8](/filings/0001690820-26-000035.md) | [2.0](/filings/0001690820-26-000055.md) |
| Total liabilities | $bn | [7.2](/filings/0001690820-23-000323.md) | [7.5](/filings/0001690820-25-000074.md) | [7.3](/filings/0001690820-24-000165.md) | [7.1](/filings/0001690820-24-000272.md) | [7.1](/filings/0001690820-24-000345.md) | [7.1](/filings/0001690820-26-000009.md) | [7.1](/filings/0001690820-25-000161.md) | [7.2](/filings/0001690820-25-000312.md) | [6.9](/filings/0001690820-25-000353.md) | [9.0](/filings/0001690820-26-000055.md) | [9.1](/filings/0001690820-26-000035.md) | [9.4](/filings/0001690820-26-000055.md) |
| Long-term debt | $bn | [5.3](/filings/0001690820-23-000323.md) | [5.4](/filings/0001690820-25-000074.md) | [5.5](/filings/0001690820-24-000165.md) | [5.4](/filings/0001690820-24-000272.md) | [5.4](/filings/0001690820-24-000345.md) | [5.3](/filings/0001690820-26-000009.md) | [5.3](/filings/0001690820-25-000161.md) | [5.3](/filings/0001690820-25-000312.md) | [4.8](/filings/0001690820-25-000353.md) | [4.8](/filings/0001690820-26-000055.md) | [4.8](/filings/0001690820-26-000035.md) | [4.9](/filings/0001690820-26-000055.md) |
| Current portion of debt | $bn | [0.5](/filings/0001690820-23-000323.md) | [0.8](/filings/0001690820-25-000074.md) | [0.4](/filings/0001690820-24-000165.md) | [0.2](/filings/0001690820-24-000272.md) | [0.2](/filings/0001690820-24-000345.md) | [0.3](/filings/0001690820-26-000009.md) | [0.3](/filings/0001690820-25-000161.md) | [0.3](/filings/0001690820-25-000312.md) | [0.3](/filings/0001690820-25-000353.md) | [0.2](/filings/0001690820-26-000055.md) | [0.2](/filings/0001690820-26-000035.md) | [0.3](/filings/0001690820-26-000055.md) |
| Shareholders' equity | $bn | [0.3](/filings/0001690820-23-000323.md) | [0.2](/filings/0001690820-25-000074.md) | [0.3](/filings/0001690820-24-000165.md) | [0.5](/filings/0001690820-24-000272.md) | [0.6](/filings/0001690820-24-000345.md) | [1.3](/filings/0001690820-26-000009.md) | [1.5](/filings/0001690820-25-000161.md) | [1.7](/filings/0001690820-25-000312.md) | [2.3](/filings/0001690820-25-000353.md) | [3.4](/filings/0001690820-26-000055.md) | [3.7](/filings/0001690820-26-000035.md) | [4.0](/filings/0001690820-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [599 d](/filings/0001690820-24-000345.md) | [(239) d](/filings/0001690820-26-000009.md) | [101](/filings/0001690820-25-000161.md) | [354 d](/filings/0001690820-25-000312.md) | [403 d](/filings/0001690820-25-000353.md) | [60.0 d](/filings/0001690820-26-000009.md) | [232](/filings/0001690820-26-000035.md) | [29.0 d](/filings/0001690820-26-000055.md) | [345 d](/filings/0001690820-25-000353.md) | [430 d](/filings/0001690820-26-000009.md) | [107](/filings/0001690820-26-000035.md) | [238 d](/filings/0001690820-26-000055.md) |
| Capital expenditure | $m | [19.0 d](/filings/0001690820-24-000345.md) | [18.0 d](/filings/0001690820-26-000009.md) | [18.0](/filings/0001690820-25-000161.md) | [22.0 d](/filings/0001690820-25-000312.md) | [27.0 d](/filings/0001690820-25-000353.md) | [24.0 d](/filings/0001690820-26-000009.md) | [27.0](/filings/0001690820-26-000035.md) | [31.0 d](/filings/0001690820-26-000055.md) | [38.0 d](/filings/0001690820-25-000353.md) | [51.0 d](/filings/0001690820-26-000009.md) | [51.0](/filings/0001690820-26-000035.md) | [51.0 d](/filings/0001690820-26-000055.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2022 (2022-06-30) | Q2 FY2023 (2023-06-30) | Q2 FY2025 (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [70.0](/filings/0001690820-21-000310.md) | [78.1](/filings/0001690820-22-000166.md) | [101](/filings/0001690820-23-000219.md) | [106](/filings/0001690820-23-000219.md) | [716](/filings/0001690820-26-000055.md) | [740](/filings/0001690820-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.